Skip to content

Prospective multicentre evaluation of the Versius surgical robotic system in paediatric urology: Initial clinical experience from the first 60 procedures.

Oct 2026 · Journal of Pediatric Urology · pp. 106335 · 0 citations · 12 references
Medicine

Abstract

Purpose

Robotic-assisted surgery uptake has been slower in paediatrics than in adult practice, partly due to concerns regarding instrument size and access to small patients. The Versius Surgical System incorporates a modular design and 5 mm wristed instruments that may address some of these challenges. We report interim results from the first 60 procedures of a world first prospective multicentre study assessing the safety and efficacy of the Versius system in paediatric urological surgery.

Methods

This prospective, multicentre, cohort study was conducted across three UK paediatric urology centres following ethics and regulatory approval. Patients younger than 18 years undergoing minimally invasive urological procedures were eligible for inclusion. Pre-, intra- and postoperative data were collected prospectively, including operative outcomes, complications, device-related events and follow-up findings. The primary endpoints were procedural safety and efficacy. Interim analysis was performed after the first 60 procedures with 3-month follow-up.

Results

Sixty procedures were performed in 59 patients by six consultant surgeons. Median patient age was 9.9 years (range 4 months-17.8 years) and median weight was 32.3 kg (range 6.1-104.0 kg). Procedures included pyeloplasty (n = 41), ureteric reimplantation (n = 7), urachal remnant excision (n = 5), nephrectomy (n = 3), ileal conduit formation (n = 2) and Mitrofanoff formation (n = 2). Fifty-nine procedures (98.3%) were completed robotically, with one conversion to open surgery due to challenging anatomy. Median operative time was 195.5 min (range 61-718 min), median blood loss was 0 mL (range 0-25 mL), and median hospital stay was 2 days (range 0-7 days). No patient required blood transfusion. Fifteen procedure-related complications occurred in 13 patients, giving a 90-day complication rate of 25%; all were considered unrelated to the robotic system. Three complications were Clavien-Dindo grade III and one patient (1.7%) required unplanned reoperation. Nine minor technical issues and two user errors were recorded, none resulting in conversion, complications or patient harm.

Conclusions

These interim results demonstrate that the Versius Surgical System can be used safely and effectively across a broad range of paediatric urological procedures and patient sizes. High robotic completion rates, low blood loss, acceptable complication rates and absence of device-related adverse events support continued evaluation of the system within the full 150-patient study cohort.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.